DCT

2022 Kia Forte Arrives with New Design and Array of Advanced Technology

Friday, December 3, 2021 - 4:17pm

The design enhancements, coupled with increased safety and improved performance continue to deliver a truly fun-to-drive experience.

Key Points: 
  • The design enhancements, coupled with increased safety and improved performance continue to deliver a truly fun-to-drive experience.
  • At the top of the lineup, the Forte and Forte5 GT Limited brings a true performance experience with a turbo 4-cylinder engine.
  • The exterior of the 2022 Forte incorporates a new design identity with enhanced styling elements in the front and rear.
  • Forte5: GT, GT Limited)
    The 2022 Forte and Forte5 receives several enhancements to its suite of Advanced Driver Assistance Systems (ADAS)ii.

CenterWatch Announces Simplifying Oncology Trials: Make the Most of Remote Monitoring and Decentralization Webinar Sponsored by Medable Inc. Dec. 8, 2021

Wednesday, December 1, 2021 - 7:00pm

FALLS CHURCH, Va., Dec. 1, 2021 /PRNewswire-PRWeb/ -- Simplifying Oncology Trials:

Key Points: 
  • FALLS CHURCH, Va., Dec. 1, 2021 /PRNewswire-PRWeb/ -- Simplifying Oncology Trials:
    While the pandemic may have initiated an oncology trial revolution think remote monitoring, decentralization these changes are here to stay.
  • Use them to one's advantage with this free webinar.
  • Such innovative methods for remote monitoring are more efficient, cost-effective and potentially improve outcomes.
  • Take advantage of remote monitoring and decentralization while improving outcomes and lowering costs with this free webinar.

CRIO Continues Record Growth for 2021 as Customers Recognize Value and Efficiency Gains of eSource

Wednesday, December 1, 2021 - 1:33pm

Highlights for CRIO's breakthrough 2021 include:

Key Points: 
  • Highlights for CRIO's breakthrough 2021 include:
    "The benefits of our eSource offering have really hit home in the life science and CRO industry," said Raymond Nomizu, CEO, CRIO.
  • "We have seen growth in all of our market segments including clinical research sites, sponsors and CROs.
  • Our eSource solutions enable us to streamline clinical research, bringing new medications to market faster for pharma and biotechs."
  • CRIO has established itself as the highest quality and most cost-effective partner for clinical trial data capture.

Parks Associates: Adoption of Connected Medical Devices has Increased to 25% of US Broadband Households in 2021

Tuesday, November 30, 2021 - 2:15pm

The research firm reports that 55% of US broadband households now own a connected health device , while adoption of connected medical devices, which includes smart thermometers, connected blood-pressure cuffs, and wireless CPAP machines, increased from 15% in 2020 to 25% in 2021.

Key Points: 
  • The research firm reports that 55% of US broadband households now own a connected health device , while adoption of connected medical devices, which includes smart thermometers, connected blood-pressure cuffs, and wireless CPAP machines, increased from 15% in 2020 to 25% in 2021.
  • "Consumers recognize value in the ability to share data from their devices or apps," said Kristen Hanich , Sr. Analyst, Parks Associates.
  • "Interoperability is critical for extending the value of connected devices and services in remote patient care."
  • Connected Health Summit: Consumer Engagement and Innovation is a virtual executive conference focused on the impact of connected devices and IoT healthcare solutions on consumers at home.

Curebase's Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

Tuesday, November 30, 2021 - 1:07pm

The enhanced feature streamlines the virtual visit process for both study participants and clinical researchers

Key Points: 
  • The enhanced feature streamlines the virtual visit process for both study participants and clinical researchers
    The telemedicine feature in Curebase's DCT platform is an organically built videoconference solution created specifically to meet the needs of clinical trials.
  • Edesa Biotech is using the Curebase telemedicine solution as part of a Phase 2b trial for an anti-inflammatory drug for which the Canada-based company is developing for chronic allergic contact dermatitis.
  • The Curebase platform's telemedicine feature allows this to be done remotely as an option in the study now.
  • Curebase is currently using its enhanced telemedicine feature on multiple clinical trials, adapted to a variety of indication and protocol designs.

The CBR1000RR-R Fireblade SP 30th Anniversary and New ADV350 Headline Honda's 2021 EICMA Line-up

Wednesday, November 24, 2021 - 12:57am

Headlining Honda's EICMA line-up is the new CBR1000RR-R Fireblade, Fireblade SP and Fireblade SP 30th Anniversary.

Key Points: 
  • Headlining Honda's EICMA line-up is the new CBR1000RR-R Fireblade, Fireblade SP and Fireblade SP 30th Anniversary.
  • To celebrate the original, ground-breaking Fireblade and 30 years of continuous challenges since the introduction of that 1992 game-changer, a stunning Limited Edition 30th Anniversary version of the Fireblade SP will be available in 2022.
  • The final drive sprocket also goes up 3 teeth, to 43, further boosting acceleration through each ratio.
  • A new material and surface finish for the Fireblade's front Nissin brake calipers' pistons improves braking performance and consistency in race conditions.

Science 37® Reveals a Pivotal Shift in the Clinical Trials Landscape

Wednesday, November 17, 2021 - 12:55pm

LOS ANGELES, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (Science 37), pioneer of decentralization and Operating System for todays more agile clinical trials, has published new data suggesting that the clinical research industry has reached a pivotal shift in the way that clinical trials are conducted, as Sponsors and CROs report they plan to run more agile (or hybrid) clinical trials in 2022 than traditional, site-based studies.

Key Points: 
  • LOS ANGELES, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (Science 37), pioneer of decentralization and Operating System for todays more agile clinical trials, has published new data suggesting that the clinical research industry has reached a pivotal shift in the way that clinical trials are conducted, as Sponsors and CROs report they plan to run more agile (or hybrid) clinical trials in 2022 than traditional, site-based studies.
  • Nearly eight of 10 respondents said they plan to run an agile clinical trial in the next 12 months.
  • The power of increased decentralization is becoming undeniable as more sponsors benefit from faster enrollment, greater retention and increased diversity, said David Coman, Chief Executive Officer at Science 37.
  • As a pioneer of decentralized clinical trials, the Science 37 Clinical Trial Operating System (OS) supports todays more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices.

EPAM Debuts New Cloud-Powered Digital Clinical Trials Platform

Wednesday, November 17, 2021 - 3:02pm

EPAM Systems, Inc. (NYSE: EPAM),a leading digital transformation services and product engineering company, announced today the launch of their new Digital Clinical Trials (DCT) platform .

Key Points: 
  • EPAM Systems, Inc. (NYSE: EPAM),a leading digital transformation services and product engineering company, announced today the launch of their new Digital Clinical Trials (DCT) platform .
  • Powered by Microsoft cloud services, the solution is a digital, patient-centric platform that connects patients, Clinical Research Organizations (CRO), and healthcare provider teams to deliver the future of hybrid or decentralized clinical trials through a virtual, effortless, outcome-driven experiencemaking them more accessible, affordable, and faster.
  • Accelerate study start-up timelines by facilitating easy document exchange between sponsor teams and trial site teams
    "We're pleased to partner with Microsoft cloud services to bring the Digital Clinical Trials platform to market," said Sergey Yezhkov, SVP and Co-Head Global Business, EPAM Systems.
  • Since 1993, EPAM Systems, Inc. (NYSE: EPAM) has leveraged its advanced software engineering heritage to become the foremost global digital transformation services provider leading the industry in digital and physical product development and digital platform engineering services.

EmpiraMed Debuts the First Patient-Centered Clinic Data Capture System

Wednesday, November 17, 2021 - 1:42pm

The PMR Portal allows clinical study sponsors to capture clinic site data without the burden, expense, or delays related to clinical trial research agreements.

Key Points: 
  • The PMR Portal allows clinical study sponsors to capture clinic site data without the burden, expense, or delays related to clinical trial research agreements.
  • EmpiraMed was the first company to run site-less studies while leading the way in engaging patients to self-report data using the PRO Portal.
  • Now, EmpiraMed is pioneering engaging patients to capture clinic data from their providers using the PMR Portal.
  • "The PMR Portal will help biopharmaceutical companies capture clinic data without burdening sites, lower clinical trial costs, and improve patient engagement and study compliance."

New Independent Survey Reveals That Only 50% of Parents Who Tried to Access Mental Health Resources for a Child During the Pandemic Were Able To

Tuesday, November 16, 2021 - 2:00pm

The survey found that only half of U.S. children whose parents tried to access mental healthcare resources during the pandemic, were able to get the care they needed.

Key Points: 
  • The survey found that only half of U.S. children whose parents tried to access mental healthcare resources during the pandemic, were able to get the care they needed.
  • In fact, 78% of survey respondents believe that educational and healthcare systems should do more to provide better mental health services to children.
  • More than half of parents and guardians queried (56%) said they experienced their own mental health challenges during the pandemic.
  • One third (33%) of parents who said they and their child experienced mental health challenges due to the pandemic did not try to access mental health care for their children.